These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 36918500

  • 1. Impact of Solid-State Properties on the Aerosolization Performance of Spray-Dried Curcumin Powders.
    Zhang Q, Li Y, Li L, Cheng Y, Yu F, Li R, Hou S.
    AAPS PharmSciTech; 2023 Mar 14; 24(3):78. PubMed ID: 36918500
    [Abstract] [Full Text] [Related]

  • 2. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
    Li L, Sun S, Parumasivam T, Denman JA, Gengenbach T, Tang P, Mao S, Chan HK.
    Eur J Pharm Biopharm; 2016 May 14; 102():132-41. PubMed ID: 26970252
    [Abstract] [Full Text] [Related]

  • 3. The use of hydrophobic amino acids in protecting spray dried trehalose formulations against moisture-induced changes.
    Mah PT, O'Connell P, Focaroli S, Lundy R, O'Mahony TF, Hastedt JE, Gitlin I, Oscarson S, Fahy JV, Healy AM.
    Eur J Pharm Biopharm; 2019 Nov 14; 144():139-153. PubMed ID: 31536784
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhalable ceftazidime-roflumilast powder targeting infection and inflammation: Influence of incorporating roflumilast into ceftazidime-leucine co-amorphous formulation.
    Raj Adhikari B, Sinha S, Lyons N, Pletzer D, Lamont I, Gordon KC, Das SC.
    Eur J Pharm Biopharm; 2022 Nov 14; 180():260-268. PubMed ID: 36241076
    [Abstract] [Full Text] [Related]

  • 6. Investigation of L-leucine in reducing the moisture-induced deterioration of spray-dried salbutamol sulfate power for inhalation.
    Li L, Leung SSY, Gengenbach T, Yu J, Gao GF, Tang P, Zhou QT, Chan HK.
    Int J Pharm; 2017 Sep 15; 530(1-2):30-39. PubMed ID: 28709940
    [Abstract] [Full Text] [Related]

  • 7. Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis.
    Eedara BB, Tucker IG, Das SC.
    Int J Pharm; 2016 Jun 15; 506(1-2):174-83. PubMed ID: 27091294
    [Abstract] [Full Text] [Related]

  • 8. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.
    Shetty N, Park H, Zemlyanov D, Mangal S, Bhujbal S, Zhou QT.
    Int J Pharm; 2018 Jun 10; 544(1):222-234. PubMed ID: 29678544
    [Abstract] [Full Text] [Related]

  • 9. Spray dried inhalable ivacaftor co-amorphous microparticle formulations with leucine achieved enhanced in vitro dissolution and superior aerosol performance.
    Guan J, Yuan H, Yu S, Mao S, Tony Zhou Q.
    Int J Pharm; 2022 Jun 25; 622():121859. PubMed ID: 35643348
    [Abstract] [Full Text] [Related]

  • 10. Development and characterization of a spray-dried inhalable ciprofloxacin-quercetin co-amorphous system.
    Alhajj N, O'Reilly NJ, Cathcart H.
    Int J Pharm; 2022 Apr 25; 618():121657. PubMed ID: 35288220
    [Abstract] [Full Text] [Related]

  • 11. Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
    Shetty N, Ahn P, Park H, Bhujbal S, Zemlyanov D, Cavallaro A, Mangal S, Li J, Zhou QT.
    Mol Pharm; 2018 Sep 04; 15(9):4004-4020. PubMed ID: 30028947
    [Abstract] [Full Text] [Related]

  • 12. Amorphicity and Aerosolization of Soluplus-Based Inhalable Spray Dried Powders.
    Adhikari BR, Das SC.
    Pharmaceutics; 2022 Nov 27; 14(12):. PubMed ID: 36559112
    [Abstract] [Full Text] [Related]

  • 13. Dry powder formulation of kanamycin with enhanced aerosolization efficiency for drug-resistant tuberculosis.
    Momin MAM, Sinha S, Tucker IG, Doyle C, Das SC.
    Int J Pharm; 2017 Aug 07; 528(1-2):107-117. PubMed ID: 28583333
    [Abstract] [Full Text] [Related]

  • 14. Engineering of levodopa inhalable microparticles in combination with leucine and dipalmitoylphosphatidylcholine by spray drying technique.
    Bahrainian S, Mirmoeini MS, Gilani Z, Gilani K.
    Eur J Pharm Sci; 2021 Dec 01; 167():106008. PubMed ID: 34530077
    [Abstract] [Full Text] [Related]

  • 15. Investigation of the Changes in Aerosolization Behavior Between the Jet-Milled and Spray-Dried Colistin Powders Through Surface Energy Characterization.
    Jong T, Li J, Morton DA, Zhou QT, Larson I.
    J Pharm Sci; 2016 Mar 01; 105(3):1156-63. PubMed ID: 26886330
    [Abstract] [Full Text] [Related]

  • 16. Physico-Chemical Properties, Aerosolization and Dissolution of Co-Spray Dried Azithromycin Particles with L-Leucine for Inhalation.
    Mangal S, Nie H, Xu R, Guo R, Cavallaro A, Zemlyanov D, Zhou QT.
    Pharm Res; 2018 Jan 08; 35(2):28. PubMed ID: 29374368
    [Abstract] [Full Text] [Related]

  • 17. Characterization of excipient enhanced growth (EEG) tobramycin dry powder aerosol formulations.
    Hassan A, Farkas D, Longest W, Hindle M.
    Int J Pharm; 2020 Dec 15; 591():120027. PubMed ID: 33130220
    [Abstract] [Full Text] [Related]

  • 18. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.
    Yu J, Chan HK, Gengenbach T, Denman JA.
    Eur J Pharm Biopharm; 2017 Oct 15; 119():224-234. PubMed ID: 28655664
    [Abstract] [Full Text] [Related]

  • 19. Understanding the impact of mannitol on physical stability and aerosolization of spray-dried protein powders for inhalation.
    Arte KS, Tower CW, Mutukuri TT, Chen Y, Patel SM, Munson EJ, Tony Zhou Q.
    Int J Pharm; 2024 Jan 25; 650():123698. PubMed ID: 38081559
    [Abstract] [Full Text] [Related]

  • 20. Development of excipients free inhalable co-spray-dried tobramycin and diclofenac formulations for cystic fibrosis using two and three fluid nozzles.
    Marasini N, Sheikh Z, Wong CYJ, Hosseini M, Spicer PT, Young P, Xin Ong H, Traini D.
    Int J Pharm; 2022 Aug 25; 624():121989. PubMed ID: 35809834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.